Skip to content
CRNX Crinetics Pharmaceuticals, Inc.
$57.18 1.20% +0.68
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CRNX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 5.4B
Enterprise value 4.5B
Trailing PE -15.520325203252
Forward PE -14.867876
PEG Ratio -14.867876
Enterprise to EBITDA -14.76
Enterprise to revenue 4325.759
Price to book MRQ 5.5696816
Price to sales TTM 5164.5254

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter (MRQ) 2024-09-30
Revenue (TTM) 1M
EBITDA -304508000
Diluted EPS TTM -3.7
Total Cash (MRQ) 862.7M
Current ratio (MRQ) 16.385
Operating Cash Flow (TTM) -199811008

CRNX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent CRNX News

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.